260 related articles for article (PubMed ID: 21224931)
1. Ranolazine: a new approach to treating an old problem.
Reddy BM; Weintraub HS; Schwartzbard AZ
Tex Heart Inst J; 2010; 37(6):641-7. PubMed ID: 21224931
[TBL] [Abstract][Full Text] [Related]
2. Update on ranolazine in the management of angina.
Codolosa JN; Acharjee S; Figueredo VM
Vasc Health Risk Manag; 2014; 10():353-62. PubMed ID: 25028555
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine: effects on ischemic heart.
Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation.
Verrier RL; Kumar K; Nieminen T; Belardinelli L
Europace; 2013 Mar; 15(3):317-24. PubMed ID: 23220484
[TBL] [Abstract][Full Text] [Related]
7. The antiarrhythmic effects of ranolazine.
Foster NJ; Haines DE
Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
[TBL] [Abstract][Full Text] [Related]
8. [Ranolazine--an additional anti-anginal drug].
Michels G; Kochanek M; Hoppe UC
Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine in the management of chronic stable angina.
Zerumsky K; McBride BF
Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
[TBL] [Abstract][Full Text] [Related]
10. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
Thadani U
Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine for the management of coronary artery disease.
Cheng JW
Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
13. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
Ling H; Packard KA; Burns TL; Hilleman DE
Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
[TBL] [Abstract][Full Text] [Related]
14. Emerging treatment options for refractory angina pectoris: ranolazine, shock wave treatment, and cell-based therapies.
Gennari M; Gambini E; Bassetti B; Capogrossi M; Pompilio G
Rev Cardiovasc Med; 2014; 15(1):31-7. PubMed ID: 24762464
[TBL] [Abstract][Full Text] [Related]
15. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
16. [Symptomatic coronary heart disease therapy: ranolazine reduces frequency of angina in diabetic patients].
MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260912
[No Abstract] [Full Text] [Related]
17. New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Maier LS
Curr Heart Fail Rep; 2012 Sep; 9(3):183-91. PubMed ID: 22767404
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine: clinical applications and therapeutic basis.
Hawwa N; Menon V
Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347
[TBL] [Abstract][Full Text] [Related]
19. Late sodium current inhibition as a new cardioprotective approach.
Hale SL; Shryock JC; Belardinelli L; Sweeney M; Kloner RA
J Mol Cell Cardiol; 2008 Jun; 44(6):954-967. PubMed ID: 18462746
[TBL] [Abstract][Full Text] [Related]
20. Utility of ranolazine in chronic stable angina patients.
Patel PD; Arora RR
Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
